about
Histone Posttranslational Modifications of CD4⁺ T Cell in Autoimmune DiseasesHuman CLEC16A regulates autophagy through modulating mTOR activity.Secondary acute myeloid leukaemia with 7q- complicating azathioprine treatment for rheumatoid arthritis.MicroRNA Regulation in Systemic Lupus Erythematosus PathogenesisAPLAR rheumatoid arthritis treatment recommendations.Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).Systemic Lupus Erythematosus Patients Exhibit Reduced Expression of CLEC16A Isoforms in Peripheral LeukocytesFrequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort.Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study.MicroRNA-155 Mediates Augmented CD40 Expression in Bone Marrow Derived Plasmacytoid Dendritic Cells in Symptomatic Lupus-Prone NZB/W F1 MiceIncreased Set1 binding at the promoter induces aberrant epigenetic alterations and up-regulates cyclic adenosine 5'-monophosphate response element modulator alpha in systemic lupus erythematosus.How we flipped the medical classroom.Lupus in the far east: a modern epidemic.Spontaneous pneumomediastinum in a dermatomyositis patient with anti-melanoma differentiation-associated gene-5 antibody and interstitial lung disease despite an initial response to immunosuppressant.Development and implementation of Models of Care for musculoskeletal conditions in middle-income and low-income Asian countries.Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials.Transcriptional and epigenetic regulation of follicular T-helper cells and their role in autoimmunity.Structural Brain Network Reorganization in Patients with Neuropsychiatric Systemic Lupus Erythematosus.Defining criteria for rheumatoid arthritis patient-derived disease activity score that correspond to Disease Activity Score 28 and Clinical Disease Activity Index based disease states and response criteria.Pyrexia, massive hepatomegaly, and extreme hyperferritinemia.Epidemiology: The effects of AIDS on the prevalence of rheumatic diseases.Disease activity assessment in ankylosing spondylitis in a Chinese cohort: BASDAI or ASDAS?Implementation of an interprofessional team-based learning program involving seven undergraduate health and social care programs from two universities, and students' evaluation of their readiness for interprofessional learning.Dosing down and then discontinuing biologic therapy in rheumatoid arthritis: a review of the literature.Ten-year progression of coronary artery, carotid artery, and aortic calcification in patients with rheumatoid arthritis.Prevalence of depressive and anxiety disorders and validation of the Hospital Anxiety and Depression Scale as a screening tool in axial spondyloarthritis patients.Obituary: Professor Sir David Todd.Left ventricular myocardial dysfunction and premature atherosclerosis in patients with axial spondyloarthritis.Does expert opinion match the operational definition of the Lupus Low Disease Activity State (LLDAS)? A case-based construct validity study.A patient with anaphylaxis to diphenhydramine without cross-reactivity to loratadine.Recall Urticaria in Adalimumab Hypersensitivity.Alternatively activated dendritic cells derived from systemic lupus erythematosus patients have tolerogenic phenotype and function.The expression of Bcl-6 in circulating follicular helper-like T cells positively correlates with the disease activity in systemic lupus erythematosus.Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study.A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosusDevelopment of the Asia Pacific Lupus Collaboration cohortDiffusion-weighted imaging versus short tau inversion recovery sequence: Usefulness in detection of active sacroiliitis and early diagnosis of axial spondyloarthritisPathogenic role of tissue-resident memory T cells in autoimmune diseasesPerceptions of Chinese Towards Dementia in Hong Kong-Diagnosis, Symptoms and ImpactsSystemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression
P50
Q28077926-212CFBD7-CF79-467E-9342-83C87CC74086Q30981879-CB4BAB19-919F-4316-9E26-57387812BCB0Q33567063-77C81E8F-1621-425C-9CF4-E5AD90F46166Q33838816-AF51200F-2EC7-4CC5-B9B1-94777C0D08E4Q35762912-E225F7C9-B7D3-41FB-A88B-F420B3FFFF1EQ35803646-5321448E-1085-4946-9731-E19930C7DBE9Q35902390-79A6E31E-2A21-4E39-8C6E-0085197459ACQ36188027-D8E7D6F0-C003-460E-AFFB-A31A5DA097C9Q36315477-5410FC2F-39F7-43F5-AB9E-2A4401160507Q37210049-7124C278-CCB7-4E57-B420-4BEED6D9CE9DQ37436786-F13A3EBD-ADCF-4A99-B4DA-1599A5EF5D08Q38220643-6F9E3ADF-70BA-42FE-8E3A-169FB71B2FCBQ38672989-563C3902-4906-4599-9C3D-F0677105543AQ38674832-1AF3364B-A436-4C4D-8C8B-788376093086Q38790745-C751C539-050B-49F5-8E25-1F2194515BC4Q39063790-4C65A814-6D26-4D5C-937F-46C3B2F303DEQ39163678-CAA496A1-AB95-4BCC-9446-7B8DAB54082DQ39384471-C0D5F55F-C01F-400A-BB58-185D412101CDQ39539735-F44E3AD5-2150-4E61-A46C-805B5A9C09C9Q40213110-B3C2B9C5-C589-4766-A46B-B52492BC32C5Q40459534-F050ADF9-8A81-4B63-A525-9D664EB81833Q43829330-AA0E3936-E3E7-40CA-8AD5-887BF61DD80BQ47102170-08F70FBF-F300-4FC5-962E-0A20206BA839Q47687442-AF388834-9B6D-4963-BF10-A8215B6D1701Q47878182-37578BBC-E87E-4295-8B03-EB27B992534FQ48196645-6DE67EF2-057F-452E-B7F0-0DAE0E68DE3BQ48262748-986F4FCB-6D41-4366-9C74-D8303448E8C4Q48574151-11C2B54E-8BF0-4CDE-9730-7A8022A1EE7BQ48694272-187BAF60-7637-494F-AA89-2476487D61D7Q49358160-7EB811E8-530E-4DC0-9789-1B1B85A7E04DQ49642237-3422C66F-1171-40B0-84A2-7F842D015492Q50766162-D5FE4A9A-934C-4579-B90C-6FDEF4D5D556Q51341694-1D5D5A93-C8D6-47E3-8575-E8302A3726F4Q54963891-E1F99A9C-0971-4FAE-B168-9C75D4D1F480Q57164496-695E5E58-8F14-4530-B3F3-E155CDDD2C40Q58610580-54DD0BB3-4580-4FF7-958D-A1B7E8F74379Q58797988-7194E1C2-030D-4AAD-A6D2-DA44DEC4A3B3Q60355860-25A58F25-A4C9-49F0-824C-8AB6CAD73242Q61451045-AC8439AE-C675-4E50-9DCD-9B0FD18B945CQ81638110-6176C44A-3D93-4FE2-8FA1-1230A414A564
P50
description
researcher
@en
name
C S Lau
@en
C S Lau
@nl
type
label
C S Lau
@en
C S Lau
@nl
prefLabel
C S Lau
@en
C S Lau
@nl
P106
P31
P496
0000-0001-6698-8355